Novo Nordisk A/S vs Pfizer Inc.
Market cap comparison over time
Novo Nordisk A/S
$147.3B
Rank #118
Pfizer Inc.
$151.7B
Rank #114
Market Cap Over Time
Key Moments
- Novo Nordisk A/S overtook Pfizer Inc. by 2023
- Pfizer Inc. overtook Novo Nordisk A/S by 2026
Year-by-Year Comparison
| Year | Novo Nordisk A/S | Pfizer Inc. | Leader |
|---|---|---|---|
| 2026 | $147.3B | $151.7B | Pfizer Inc. |
| 2025 | $152.9B | $137.3B | Novo Nordisk A/S |
| 2024 | $285.3B | $136.4B | Novo Nordisk A/S |
| 2023 | $315.6B | $139.5B | Novo Nordisk A/S |
| 2022 | $209.4B | $237.5B | Pfizer Inc. |
| 2021 | $161.6B | $265.1B | Pfizer Inc. |
| 2020 | $92.0B | $159.1B | Pfizer Inc. |
| 2019 | $81.6B | $154.3B | Pfizer Inc. |
| 2018 | $61.4B | $165.8B | Pfizer Inc. |
| 2017 | $67.2B | $132.8B | Pfizer Inc. |
| 2016 | $49.6B | $114.6B | Pfizer Inc. |
| 2015 | $75.8B | $109.7B | Pfizer Inc. |
| 2014 | $48.6B | $102.5B | Pfizer Inc. |
| 2013 | $36.5B | $97.3B | Pfizer Inc. |
| 2012 | $33.0B | $77.1B | Pfizer Inc. |
| 2011 | $23.3B | $64.0B | Pfizer Inc. |
| 2010 | $43.8B | $49.7B | Pfizer Inc. |
| 2009 | $22.7B | $49.6B | Pfizer Inc. |
| 2008 | $9.1B | $45.8B | Pfizer Inc. |
| 2007 | $22.1B | $55.2B | Pfizer Inc. |
| 2006 | $7.7B | $60.1B | Pfizer Inc. |
| 2005 | $5.7B | $52.1B | Pfizer Inc. |
| 2004 | $9.4B | $58.3B | Pfizer Inc. |
| 2003 | $7.5B | $75.0B | Pfizer Inc. |
| 2002 | $6.2B | $63.7B | Pfizer Inc. |
| 2001 | $10.3B | $81.9B | Pfizer Inc. |